Adaptation to culture of human embryonic stem cells and oncogenesis in vivo

Nature Biotechnology

Volumn 25, Issue 2, 2007, Pages 207-215

  Baker, Duncan E C ^a   Harrison, Neil J ^b   Maltby, Edna ^a   Smith, Kath ^a   Moore, Harry D ^b   Shaw, Pamela J ^b   Heath, Paul R ^b   Holden, Hazel ^b   Andrews, Peter W ^b  

^a SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CHROMOSOMES; DRUG PRODUCTS; GENETIC ENGINEERING; ONCOLOGY;

HUMAN EMBRYONIC STEM CELLS; KARYOTYPIC ABERRATIONS; REGENERATIVE MEDICINE; SELF-RENEWING CELLS;

CELL CULTURE;

CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME 12; CHROMOSOME 17; CULTURAL ANTHROPOLOGY; CYTOGENETICS; EMBRYONIC STEM CELL; GERM CELL TUMOR; HUMAN; HUMAN EMBRYONIC STEM CELL; IN VIVO STUDY; KARYOTYPING; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL; X CHROMOSOME;

ADAPTATION, PHYSIOLOGICAL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; EMBRYONIC STEM CELLS; HUMANS; MODELS, GENETIC;

EID: 33846879559     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1285     Document Type: Review

References (78)

1. O'Neill, L.P., Vermilyea, M.D. & Turner, B.M. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat. Genet. 38, 835-841 (2006).
2. Bradley, A., Evans, M., Kaufman, M.H. & Robertson, E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256 (1984).
3. Hoffman, L.M. & Carpenter, M.K. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699-708 (2005).
4. Enver, T. et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129-3140 (2005).
5. Herszfeld, D. et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 24, 351-357 (2006).
6. Andrews, P.W. et al. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 33, 1526-1530 (2005).
7. Liu, Y. et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev. Biol. 6, 20 (2006).
8. Boveri, T. The origin of malignant tumours (Williams and Walkin, Baltimore, 1914).
9. Oosterhuis, J.W. & Looijenga, L.H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 5, 210-222 (2005).
10. Damjanov, I. Teratocarcinoma stem cells. Cancer Surv. 9, 303-319 (1990).
11. Moller, H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur. Urol. 23, 8-13; discussion 14-15 (1993).
12. Damjanov, I. Pathogenesis of testicular germ cell tumours. Eur. Urol. 23, 2-5; discussion 6-7 (1993).
13. Andrews, P.W. From teratocarcinomas to embryonic stem cells. Phil. Trans. R. Soc. Lond. B 357, 405-417 (2002).
14. Draper, J.S. et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22, 53-54 (2004).
15. Mitalipova, M.M. et al. Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20 (2005).
16. Brimble, S.N. et al. Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev. 13, 585-597 (2004).
17. Buzzard, J.J., Gough, N.M., Crook, J.M. & Colman, A. Karyotype of human ES cells during extended culture. Nat Biotechnol. 22, 381-382; author reply 382 (2004).
18. Imreh, M.P. et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J. Cell. Biochem. 99, 508-516 (2006).
19. Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099-1103 (2005).
20. Josephson, R. et al. A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol. 4, 28 (2006).
21. Reuter, V.E. Origins and molecular biology of testicular germ cell tumors. Mod. Pathol. 18 (suppl. 2), S51-S60 (2005).
22. Samaniego, F. et al. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosom. Cancer 1, 289-300 (1990).
23. Kraggerud, S.M. et al. Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosom. Cancer 34, 168-174 (2002).
24. Summersgill, B.M. et al. Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses. Cancer Genet. Cytogenet. 128, 120-129 (2001).
25. von Eyben, F.E. Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet. Cytogenet. 151, 93-138 (2004).
26. Sugawara, A., Goto, K., Sotomaru, Y., Sofuni, T. & Ito, T. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp. Med. 56, 31-34 (2006).
27. Lastowska, M. et al. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosom. Cancer 34, 428-436 (2002).
28. Tirkkonen, M. et al. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom. Cancer 21, 177-184 (1998).
29. Azuhata, T. et al. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J. Pediatr. Surg. 36, 1785-1791 (2001).
30. Cowan, C.A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356 (2004).
31. Korkola, J.E. et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66, 820-827 (2006).
32. Skotheim, R.I. et al. Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell. Oncol. 28, 315-326 (2006).
33. Roelofs, H. et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am. J. Pathol. 157, 1155-1166 (2000).
34. Zafarana, G. et al. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 22, 7695-7701 (2003).
35. Ludwig, T.E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187 (2006).
36. Inzunza, J. et al. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol. Hum. Reprod. 10, 461-466 (2004).
37. Sperger, J.M. et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 100, 13350-13355 (2003).
38. Dhara, S.K. & Benvenisty, N. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res. 32, 3995-4002 (2004).
39. Sandberg, A.A., Meloni, A.M. & Suijkerbuijk, R.F. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J. Urol. 155, 1531-1556 (1996).
40. Kawakami, T. et al. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J. Urol. 169, 1546-1552 (2003).
41. Yang, S.H., Jaffray, E., Hay, R.T. & Sharrocks, A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12, 63-74 (2003).
42. Wu, X., Noh, S.J., Zhou, G., Dixon, J.E. & Guan, K.L. Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated HeLa cells. J. Biol. Chem. 271, 3265-3271 (1996).
43. Ishitani, K. et al. p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochem. Biophys. Res. Commun. 306, 660-665 (2003).
44. Bai, V.U., Cifuentes, E., Menon, M., Barrack, E.R. & Reddy, G.P. Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase. J. Cell. Physiol. 204, 381-387 (2005).
45. Rapley, E.A. et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat. Genet. 24, 197-200 (2000).
46. bcr/abl protein. Proc. Natl. Acad. Sci. USA 85, 9312-9316 (1988).
47. Wang, N., Trend, B., Bronson, D.L. & Fraley, E.E. Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res. 40, 796-802 (1980).
48. Looijenga, L.H. et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J. Pathol. 191, 187-192 (2000).
49. Biedler, J.L. & Spengler, B.A. A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. J. Natl. Cancer Inst. 57, 683-695 (1976).
50. Benner, S.E., Wahl, G.M. & Von Hoff, D.D. Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anticancer Drugs 2, 11-25 (1991).
51. Albrecht, S., Armstrong, D.L., Mahoney, D.H., Cheek, W.R. & Cooley, L.D. Cytogenetic demonstration of gene amplification in a primary intracranial germ cell tumor. Genes Chromosom. Cancer 6, 61-63 (1993).
52. van Dartel, M. & Hulsebos, T.J. Amplification and overexpression of genes in 17p11.2 ∼ p12 in osteosarcoma. Cancer Genet. Cytogenet. 153, 77-80 (2004).
53. Skotheim, R.I. et al. Novel genomic aberrations in testicular germ cell tumours by array-CGH, and associated gene expression changes. Cell. Oncol. 28, 315-326 (2006).
54. Feng, G.S. et al. Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway. J. Biol. Chem. 271, 12129-12132 (1996).
55. Burdon, T., Smith, A. & Savatier, P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12, 432-438 (2002).
56. Kang, H.B. et al. Basic fibroblast growth factor activates ERK and induces c-fos in human embryonic stem cell line MizhES1. Stem Cells Dev. 14, 395-401 (2005).
57. Cervantes, R.B., Stringer, J.R., Shao, C., Tischfield, J.A. & Stambrook, P.J. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. USA 99, 3586-3590 (2002).
58. Hong, Y. & Stambrook, P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl. Acad. Sci. USA 101, 14443-14448 (2004).
59. Fluckiger, A.C. et al. Cell cycle features of primate embryonic stem cells. Stem Cells 24, 547-556 (2006).
60. Downes, C.S. et al. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372, 467-470 (1994).
61. Damelin, M., Sun, Y.E., Sodja, V.B. & Bestor, T.H. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8, 479-484 (2005).
62. Amon, A. The spindle checkpoint. Curr. Opin. Genet. Dev. 9, 69-75 (1999).
63. Wilton, L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat. Diagn. 22, 512-518 (2002).
64. Hardy, K. Cell death in the mammalian blastocyst. Mol. Hum. Reprod. 3, 919-925 (1997).
65. von Zglinicki, T., Pilger, R. & Sitte, N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28, 64-74 (2000).
66. Andrews, P.W. et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab. Invest. 50, 147-162 (1984).
67. Andrews, P.W., Goodfellow, P.N., Shevinsky, L.H., Bronson, D.L. & Knowles, B.B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 29, 523-531 (1982).
68. Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278 (2000).
69. Pyle, A.D., Lock, L.F. & Donovan, P.J. Neurotrophins mediate human embryonic stem cell survival. Nat. Biotechnol. 24, 344-350 (2006).
70. Liu, X. et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209, 85-91 (1997).
71. Longo, L., Bygrave, A., Grosveld, F.G. & Pandolfi, P.P. The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res. 6, 321-328 (1997).
72. Draper, J.S., Moore, H.D., Ruban, L.N., Gokhale, P.J. & Andrews, P.W. Culture and characterization of human embryonic stem cells. Stem Cells Dev. 13, 325-336 (2004).
73. Caisander, G. et al. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res. 14, 131-137 (2006).
74. Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259-274 (2004).
75. Xiao, L., Yuan, X. & Sharkis, S.J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24, 1476-1486 (2006).
76. Kim, S.J. et al. Efficient derivation of new human embryonic stem cell lines. Mol. Cells 19, 46-53 (2005).
77. Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
78. Smith, A.C. et al. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am. J. Med. Genet. 24, 393-414 (1986).